The ROE as of December 2025 (TTM) for Oryzon Genomics S.A. (ORYZF) is -4.20%

According to Oryzon Genomics S.A.’s latest financial reports and current stock price. The company's current ROE is -4.20%. This represents a change of 552.17% compared to the average of -0.64% of the last 4 quarters.

Oryzon Genomics S.A. (ORYZF) Historical ROE (quarterly & annually)

How has ORYZF ROE performed in the past?

The mean historical ROE of Oryzon Genomics S.A. over the last ten years is -2.52%. The current -4.20% ROE has changed 66.86% with respect to the historical average. Over the past ten years (40 quarters), ORYZF's ROE was at its highest in in the December 2022 quarter at 25.89%. The ROE was at its lowest in in the March 2023 quarter at -2.30%.

Oryzon Genomics S.A. (ORYZF) ROE by Quarter and Year

Discovering the peaks and valleys of Oryzon Genomics S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oryzon Genomics S.A. (ORYZF) Average ROE

How has ORYZF ROE performed in the past?

The current ROE of Oryzon Genomics S.A. (ORYZF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oryzon Genomics S.A. (ORYZF) ROE vs. Peers

How is ORYZF’s ROE compared to its peers?

Oryzon Genomics S.A.’s ROE is less than hVIVO plc (25.62%), greater than Silence Therapeutics plc (-85.88%), greater than Santhera Pharmaceuticals Holding AG (-521.53%), greater than Genfit S.A. (-63.70%), greater than Transgene S.A. (-634.16%), less than Hansa Biopharma AB (publ) (115.70%), greater than JW (Cayman) Therapeutics Co. Ltd (-59.45%), greater than NervGen Pharma Corp. (-879.68%), less than China Evergrande New Energy Vehicle Group Limited (20.82%), less than Orpea S.A. (703.78%),

Build a custom stock screener for Oryzon Genomics S.A. (ORYZF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oryzon Genomics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oryzon Genomics S.A. (ORYZF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oryzon Genomics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.